Status:
ACTIVE_NOT_RECRUITING
Quality of Life In Patients With Allergic Conjunctivitis In Treatment With Sublingual Allergen Immunotherapy In A Referral Ophthalmological Hospital
Lead Sponsor:
Instituto de Oftalmología Fundación Conde de Valenciana
Conditions:
Allergic Conjunctivitis of Both Eyes
Eligibility:
All Genders
6-86 years
Brief Summary
The goal of this observational study is to evaluate both clinical changes and quality-of-life outcomes in patients with allergic conjunctivitis treated with allergen-specific immunotherapy, integratin...
Detailed Description
BACKGROUND: Allergic conjunctivitis (AC) is an inflammatory disease of the ocular surface that may be affecting people's quality of life. Studies have shown that allergic diseases are a risk factor fo...
Eligibility Criteria
Inclusion
- Patient records containing complete information
- Both sexes
- Age range: 6 to 86 years
- Between 2018 and 2023
- Diagnosed with allergic conjunctivitis
- Who have received treatment with allergen-specific sublingual immunotherapy
- With 8 assessments from the immunology and cornea department
- With 7 quality of life questionnaires completed by the patient
Exclusion
- Patient records for other inflammatory ocular conditions
- Those with chronic diseases
- Those who have received naturopathic or immunomodulatory treatment during the follow-up period for allergen-specific sublingual immunotherapy
Key Trial Info
Start Date :
March 24 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07149298
Start Date
March 24 2014
End Date
March 1 2026
Last Update
September 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto de Oftalmología FAP Conde de Valenciana
Mexico City, Mexico, 06800